Analytical study designs.pptx

1,541 views 46 slides Oct 19, 2022
Slide 1
Slide 1 of 46
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46

About This Presentation

Observational study is divided into descriptive and analytical studies.

Non-experimental

Observational because there is no individual intervention

Treatment and exposures occur in a โ€œnon-controlledโ€ environment

Individuals can be observed prospectively or retrospectively

COHORT STUDY- an ๏ฟฝ...


Slide Content

ANALYTICAL STUDY DESIGNS - Dr. ARYASREE L.

Overview Cohort study Case control study

Observational Studies Non-experimental Observational because there is no individual intervention Treatment and exposures occur in a โ€œnon-controlledโ€ environment Individuals can be observed prospectively or retrospectively

Figure 9-3 Selection of study groups in experimental and observational epidemiologic studies .

Basic Questions in Analytic Epidemiology Look to link exposure and disease What is the exposure? Who are the exposed? What are the potential health effects? What approach will you take to study the relationship between exposure and effect?

COHORT STUDY

Cohort Studies an โ€œobservationalโ€ design comparing individuals with a known risk factor or exposure with others without the risk factor or exposure. looking for a difference in the risk (incidence) of a disease over time. best observational design data usually collected prospectively (some retrospective)

Figure 9-4 Design of a cohort study beginning with exposed and nonexposed groups. Downloaded from: StudentConsult (on 26 February 2013 06:04 AM) ยฉ 2005 Elsevier Design of cohort study

Figure 9-5 Design of a cohort study beginning with a defined population. Downloaded from: StudentConsult (on 26 February 2013 06:04 AM) ยฉ 2005 Elsevier

Cohort design Time Study begins here Study Population Free of Disease Factor Present Factor Absent Disease No disease Disease No disease Present Future

Prospective Study - looks forward, looks to the future, examines future events, follows a condition, concern or disease into the future time Study begins here

Retrospective Study - โ€œto look backโ€, looks back in time to study events that have already occurred time Study begins here

Figure 9-7 Time frame for a hypothetical retrospective cohort study begun in 2008. Downloaded from: StudentConsult (on 26 February 2013 06:04 AM) ยฉ 2005 Elsevier

Figure 9-8 Time frames for a hypothetical prospective cohort study and a hypothetical retrospective cohort study begun in 2008. Downloaded from: StudentConsult (on 26 February 2013 06:04 AM) ยฉ 2005 Elsevier

The Framingham study

Aniline dyes and urinary bladder cancer

Elements of cohort study Selection of study populations Gathering baseline information Follow up Analysis

1. Selection of study population General population Special exposure cohorts

2. Gathering baseline information Valid assessment of exposure status Exclude who are having disease of interest Data on other risk factors

3. Choice of comparison group Internal comparison group External comparison group

4. Follow up Uniform and complete follow up Complete assessment of exposures and outcomes Standardized diagnosis of outcomes

Presentation of the data in a cohort study in a 2x2 table

Relative Risk The relative risk can be defined as the probability of an event (developing a disease) occurring in exposed people compared with the probability of the event in unexposed people, or as the ratio of these two probabilities. RR= Risk in exposed Risk in unexposed

Interpreting relative risk of a disease If RR =1 Risk in exposed equal to risk in unexposed(no association) If RR >1 Risk in exposed greater than risk in unexposed(positive association;possibly causal) If RR < 1 Risk in exposed less than risk in unexposed (negative association; possibly protective)

Cohort study strengths and weaknesses Strengths weaknesses Allows calculation of incidence Long calendar time Examine multiple outcomes for a given exposure Not good for rare diseases Clarity of temporal sequence Not good for diseases with a long latency Good for investigating rare exposures Differential loss to follow up can introduce bias

Case control

Elements of case control study Selection of cases Selection of controls Information on exposure Analysis

1. Selection of cases All people in source population who develop the disease of interest Clear definition of outcome studied Prevalent vs incident cases

Sources of cases Hospital /clinic based cases Population based

2. Selection of controls Population based Health care facility based Case based

3. Collecting good data on exposure Objectively โ€“ reproducibility of exposure measurement Accurately โ€“ information reflecting as closely as possible the effect of exposure Precisely โ€“ Quality management in exposure measurement

Presentation of the data of a case control study in a 2x2 table

Odds ratio An odds ratio (OR) is a measure of association between an exposure and an outcome. The OR represents the odds that an outcome will occur given a particular exposure, compared to the odds of the outcome occurring in the absence of that exposure.

Interpreting odds ratio OR=1 Odds of exposure among cases and controls are same Exposure is not associated with disease OR>1 Odds of exposure among cases are higher than controls Exposure is positively associated with disease OR<1 Odds of exposure among cases are lower than controls Exposure is negatively associated with disease

Case control study strengths and weaknesses STRENGTHS WEAKNESSES Good for rare outcomes Susceptible to recall bias Relatively quick to conduct Selection of an appropriate comparison group may be difficult Requires comparatively few subjects Rates of disease in exposed and unexposed individuals cannot be determined Multiple exposures or risk factors can be examined

Example 1 Thyroid hormones, namely triiodothyronine (Free T3), thyroxine (Free T4) and thyroid stimulating hormone (TSH) were evaluated at the time of diagnosis of preeclampsia in 82 pregnant women and equal number of matched controls. (Kumar et al.) Case Control

Example 2 46,112 never users of oral contraception and women 819,175 ever users were followed for 39 years to ascertain mortality risk. (Hannaford et al.) Cohort

Example 3 275 women attending the antenatal clinic at Kilifi district hospital, Kenya, were recruited in November 1993 and tested for malaria in order to calculate the prevalence. (Shulman et al.) Cross-Sectional

Example 4 270 wards randomised to 3 groups of 90 each for women to receive weekly a single oral supplement of placebo, vitamin A or รข carotene for over 3.5 years and followed to determine pregnancy-related mortality. (West et al.) Clinical Trial

Example 5 A survey among second trimester pregnant women 18-44 took place between April 2003 and November 2003 to determine the prevalence of anemia and hookworm. ( Larocque et al.) Cross-Sectional

Example 6 431 women were enrolled in a study within 21 days of conception and monitored throughout pregnancy to determine caffeine exposure and pregnancy outcome. (Mills et al.) Cohort

References BCBR lecture 6 Gordis epidemiology Edition 6 National library of medicine

THANKYOU